Overall, these findings suggest that both inflammation and NPM-ALK signaling might participate in inducing high HSP90 circulating levels and in defining the composition of ALCL S-EV proteomes. The gene discussed is HSP90AB1; the disease is anaplastic large cell lymphoma.